Context Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Context Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Context Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $244K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $244K +$244K Sep 30, 2024 10-Q 2024-11-06
Q4 2023 $0 -$52K -100% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $0 -$73.8K -100% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $7.52K -$87.7K -92.1% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $29.9K -$86.6K -74.3% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $52K +$52K Dec 31, 2022 10-K 2024-03-21
Q3 2022 $73.8K Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $95.3K Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $116K Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.